OSCR

APOE4 Genotype is Associated with Reduced Cortical VEGFR2 ( <i>KDR</i> ) Transcript Levels Independent of Endothelial Abundance: An AMP-AD RNA-seq Pilot Study

Overview

Authors: Laing K1,2,3,4, Montagne A1,2,3,4
ORCID iDs: Laing K
  1. Institute for Neuroscience and Cardiovascular Research (INCR), Chancellor's Building, The University of Edinburgh, 49 Little France Crescent, Edinburgh, EH16 4SB, UK
  2. Centre for Clinical Brain Sciences (CCBS), School of Clinical Sciences, College of Medicine and Veterinary Medicine, The University of Edinburgh, Edinburgh, EH16 4SB, UK
  3. UK Dementia Research Institute (UK DRI) at the University of Edinburgh, Edinburgh, EH16 4SB, UK
  4. British Heart Foundation - UK Dementia Research Institute (BHF-UK DRI) Centre for Vascular Dementia Research (CVDR) at the University of Edinburgh, Edinburgh, EH16 4SB, UK
Institutions: University of Edinburgh (United Kingdom); UK Dementia Research Institute (United Kingdom); British Heart Foundation (United Kingdom)
Journal: bioRxiv (preprint)
Dates: published online 3 March 2026
Type: Preprint
License: CC BY
Identifiers: DOI 10.64898/2026.03.01.708815 · OpenAlex W7133325321
Open access: green, a free copy (OpenAlex)
Status: data only
Categories: genetics / omics (modality), histology / microscopy (modality), Alzheimer's / dementia (population)
Methods: Smoothing, state filtering, decompositions, Preprocessing, Statistics, fMRI & imaging
Topic: Barrier Structure and Function Studies (Neurology, Neuroscience), according to OpenAlex
Citations: not cited yet (Europe PMC); 19 references in the paper

Abstract

Background: Apolipoprotein E4 (APOE4) is the strongest common genetic risk factor for late-onset Alzheimer’s disease and has been implicated in cerebrovascular dysfunction. Vascular endothelial growth factor receptor 2 (VEGFR2), encoded by the gene KDR, is a key regulator of endothelial integrity and blood-brain barrier (BBB) maintenance; however, its relationship to APOE4 status in human brain tissue remains unclear.

Methods: Bulk RNA-sequencing data from 162 donors (n = 633 cortical samples) from the AMP-AD MSSB cohort were analysed using linear mixed-effects models with donor-level random intercepts. Models were adjusted for tissue region, age at death, sex, RNA integrity (RIN), and post-mortem interval. An endothelial composite score derived from key endothelial markers (PECAM1, VWF, CLDN5, FLT1, TEK) was included to account for endothelial signal abundance. Interaction models assessed modification by cortical region and neuropathological burden (Braak stage, CERAD score, plaque mean). A candidate panel of endothelial/BBB transcripts (KDR, CAV1, MFSD2A, CLDN5, SLC2A1, OCLN, TJP1) were also assessed in relation to APOE genotype.

Results: Bulk KDR expression varied significantly across cortical regions (p < 2×10−16) and was strongly correlated with endothelial signal abundance (r = 0.57, p < 2×10−16). APOE4 status was not associated with endothelial composite score (p = 0.78). In models adjusting for tissue and technical covariates, but not endothelial signal, APOE4 carriers showed a non-significant trend toward reduced KDR expression (β = –0.16, p = 0.064). After inclusion of the endothelial composite score, APOE4 carrier status was significantly associated with reduced KDR expression (β = –0.17, p = 0.029), corresponding to an estimated 10-15% decrease in transcript levels. The direction of effect was consistent across cortical regions, with no evidence of APOE4 × region interaction. No significant APOE4 × neuropathology interactions were observed. Among candidate transcripts, only KDR and TJP1 showed reduced expression, suggesting a selective rather than global transcriptional effect.

Conclusions: Bulk KDR transcript levels are strongly influenced by endothelial signal abundance; however, APOE4 is associated with a modest but consistent reduction in VEGFR2 expression independent of endothelial signal abundance and neuropathological severity. These findings support a model in which APOE4 contributes to vascular dysfunction through targeted endothelial alterations, rather than merely reflecting changes in endothelial cell proportion.

Reproduced under the paper's license (CC BY), from the paper cited above.

Code

The paper links to its data, not to its authors' code: see the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none, so it has no map.

Data

Datasets cited

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 1, 30 September 2026: the first record

Recorded: type, journal, dates, 2 authors, 19 references.

Cite

This paper

K, L., & A, M. (2026). APOE4 Genotype is Associated with Reduced Cortical VEGFR2 ( <i>KDR</i> ) Transcript Levels Independent of Endothelial Abundance: An AMP-AD RNA-seq Pilot Study. bioRxiv (preprint). https://doi.org/10.64898/2026.03.01.708815

BibTeX

@article{k2026apoe4,
author = {K, Laing and A, Montagne},
title = {{APOE4 Genotype is Associated with Reduced Cortical VEGFR2 ( <i>KDR</i> ) Transcript Levels Independent of Endothelial Abundance: An AMP-AD RNA-seq Pilot Study}},
journal = {bioRxiv (preprint)},
year = {2026},
month = mar,
publisher = {bioRxiv},
issn = {2692-8205},
doi = {10.64898/2026.03.01.708815},
url = {https://doi.org/10.64898/2026.03.01.708815}
}

RIS

TY - JOUR
AU - K, Laing
AU - A, Montagne
TI - APOE4 Genotype is Associated with Reduced Cortical VEGFR2 ( <i>KDR</i> ) Transcript Levels Independent of Endothelial Abundance: An AMP-AD RNA-seq Pilot Study
T2 - bioRxiv (preprint)
J2 - bioRxiv
PY - 2026
DA - 2026/03/03
SN - 2692-8205
PB - bioRxiv
DO - 10.64898/2026.03.01.708815
UR - https://doi.org/10.64898/2026.03.01.708815
ER -

CSL-JSON

{
"id": "10.64898/2026.03.01.708815",
"type": "article",
"title": "APOE4 Genotype is Associated with Reduced Cortical VEGFR2 ( <i>KDR</i> ) Transcript Levels Independent of Endothelial Abundance: An AMP-AD RNA-seq Pilot Study",
"container-title": "bioRxiv (preprint)",
"author": [
{
"family": "K",
"given": "Laing"
},
{
"family": "A",
"given": "Montagne"
}
],
"container-title-short": "bioRxiv",
"DOI": "10.64898/2026.03.01.708815",
"ISSN": "2692-8205",
"publisher": "bioRxiv",
"URL": "https://doi.org/10.64898/2026.03.01.708815",
"issued": {
"date-parts": [
[
2026,
3,
3
]
]
}
}

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1186/s13195-026-02018-3
Impact of Apolipoprotein E4 on blood-brain barrier integrity in target replacement murine models: a systematic review and meta-analysis.
Journal: Alzheimer's research & therapy
In common: Alzheimer's / dementia, 6 references
[2] doi:10.1186/s12974-026-03888-y
Integrated imaging and molecular profiling reveals APOE4-associated neurovascular and glial disruptions in young adult mice.
Journal: Journal of neuroinflammation
In common: Alzheimer's / dementia, genetics / omics, 5 references
[3] doi:10.1016/j.celrep.2026.117235 [code]
Integration of aged brain multi-omics reveals cross-system mechanisms underlying Alzheimer's disease heterogeneity.
Journal: Cell reports
In common: Alzheimer's / dementia, genetics / omics, 3 references
[4] doi:10.1038/s43587-026-01204-0
Fibronectin mediates APOE4-driven blood-brain barrier dysfunction in Alzheimer's disease.
Journal: Nature aging
In common: Alzheimer's / dementia, genetics / omics, 3 references
[5] doi:10.1038/s41467-026-68864-9 [code]
Integrative epigenomic landscape of Alzheimer's Disease brains reveals oligodendrocyte molecular perturbations associated with tau.
Journal: Nature communications
In common: Alzheimer's / dementia, genetics / omics, 3 references
[6] doi:10.1016/j.isci.2026.117038 [code]
Multi-region brain transcriptomes uncover two subtypes of aging individuals with differences in Alzheimer risk and the impact of &lt;i&gt;APOEε4&lt;/i&gt;.
Journal: iScience
In common: Alzheimer's / dementia, genetics / omics, 2 references
[7] doi:10.34133/csbj.0108 [code]
Latent Factor Modeling Reveals Unexpected Spatial Heterogeneity in Human Alzheimer's Disease Brain Transcriptomes.
Journal: Computational and structural biotechnology journal
In common: Alzheimer's / dementia, genetics / omics, 2 references
[8] doi:10.3390/ijms27083430
Metatranscriptomic Reanalysis of Alzheimer's Brains Identifies Low-Biomass Microbial Signals Including Enrichment of &lt;i&gt;Acinetobacter radioresistens&lt;/i&gt;.
Journal: International journal of molecular sciences
In common: Alzheimer's / dementia, genetics / omics, 2 references
[9] doi:10.1002/alz.71433
Genetic correlation analysis of Alzheimer's disease and stroke implicates PHLPP1 as a shared locus in individuals of African ancestry.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
In common: Alzheimer's / dementia, genetics / omics, 2 references
[10] doi:10.3389/fnagi.2026.1768436
TAS2R38 taster variants-linked MGAM expression in Alzheimer's disease: a novel target for precision drug repurposing.
Journal: Frontiers in aging neuroscience
In common: Alzheimer's / dementia, 2 references

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: questions and error reports about this paper and its code, from signed-in readers and its authors. It opens with sign-in.

Reproductions: reports from readers who ran the authors' code: what they reproduced, with which environment, commit and data. It opens with sign-in.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.